Aptahem AB is a clinical-stage biotechnology company that develops RNA-based pharmaceuticals, also known as aptamers, for the treatment of acute conditions such as sepsis.
Subscribe to see Aptahem’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aptahem is a biotech company headquartered in Sweden. Its most recent funding round raised $1.5M in September 2026. Xcout tracks 1 named person at Aptahem, including Mikael Lindstam (vd).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Aptahem's closest competitors — see the full list of competitors and alternatives →
Inotrem is a French clinical-stage biotechnology company developing therapies for dysregulated innate immune responses and inflammation. Its lead candidate, nangibotide (LR12), targets TREM-1 and has been investigated for severe sepsis and other acute inflammatory conditions, serving patients with life-threatening immune-mediated diseases.
Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions. The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc. Its corporate base of operations is located in Vancouver, Canada.
Aptadir Therapeutics is a biotechnology company based in Milan, Italy, specializing in the development of RNA inhibitor-based therapeutics. The firm focuses on creating novel treatments for intractable cancers and genetic disorders.
Adaptive Phage Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, that is advancing the APT phage bank. The company focuses on developing phage-based therapeutics to address bacterial infections.
Lipum AB is a clinical-stage biotechnology research company based in Umeå, Sweden, operating out of the Umeå Biotech Incubator at Uminova Science Park. The company focuses on discovering novel treatments and unique therapeutic approaches for chronic inflammatory diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Aptahem? Suggest a correction · Work at Aptahem? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.